APA 2018—Inpatients with cocaine and cannabis substance use disorders have different impulsivity profiles


  • Conference Reports
Der Zugang zum gesamten Inhalt dieser Seite ist nur Angehörigen medizinischer Fachkreise vorbehalten. Der Zugang zum gesamten Inhalt dieser Seite ist nur Angehörigen medizinischer Fachkreise vorbehalten.

Takeaway

  • Patients with cocaine and cannabis use disorder have different impulsivity profiles.

Why this matters

  • Substance use disorders have previously been associated with increased impulsivity.

Key results

  • Being National Institute on Drug Abuse (NIDA) risk score-positive for cannabis or cocaine use disorder was significantly associated with Barratt Impulsiveness Scale (BIS)-11 score.
    • NIDA risk score-positivity for cannabis use disorder was significantly associated with BIS-attentional and BIS-nonplanning subscores (P=.034 and .002, respectively), but not with BIS-motor subscore (P=.283).
    • NIDA risk score-positivity for cocaine use disorder was significantly associated with BIS-nonplanning subscore (P=.001), but not with BIS-motor subscore or BIS-attentional subscore (P=.293 and .067, respectively).

Study design

  • Researchers assessed impulsivity and substance use among psychiatric inpatients (n=184).
    • Impulsivity was assessed by administering the BIS-11.
    • Cannabis use and cocaine use were assessed using NIDA risk scores.
  • Funding: UT Health McGovern Medical School

Limitations

  • The study was conducted in a single center and relies on self-report data for impulsivity, and may not contain data representing the least functional patients.